Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0TA3V
|
||||
| Former ID |
DIB004172
|
||||
| Drug Name |
ADC-5510
|
||||
| Synonyms |
ADC-02265510; ADC-5510; ADL-5510; Centrally acting mu opoid receptor antagonists, Adolor
|
||||
| Indication | Movement disorder [ICD10:R25] | Investigative | [543764] | ||
| Company |
Adolor Corp
|
||||
| Canonical SMILES |
C[C@]1(c2cc(ccc2)O)[C@H](CN2C[C@@H](N(C[C@H]2C1)C(=O)c1<br />ccccc1)c1ccccc1)C
|
||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Antagonist | [543764] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

